Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,700
Employees4,700
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,700
Employees4,700

PEN Key Statistics

Market cap
12.78B
Market cap12.78B
Price-Earnings ratio
79.33
Price-Earnings ratio79.33
Dividend yield
Dividend yield
Average volume
384.59K
Average volume384.59K
High today
$323.81
High today$323.81
Low today
$322.25
Low today$322.25
Open price
$323.81
Open price$323.81
Volume
279.06K
Volume279.06K
52 Week high
$362.41
52 Week high$362.41
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

The current Penumbra(PEN) stock price is $323.21, with a market capitalization of 12.78B. The stock trades at a price-to-earnings (P/E) ratio of 79.33.

As of 2026-08-05, Penumbra(PEN) stock has fluctuated between $322.25 and $323.81. The current price stands at $323.21, placing the stock +0.3% above today's low and -0.2% off the high.

Penumbra(PEN) shares are trading with a volume of 279.06K, against a daily average of 384.59K.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

PEN News

Simply Wall St 1d
Did Penumbra's Voluntary RED 68 Catheter Recall Just Shift Its Investment Narrative?

Penumbra, Inc. recently initiated a voluntary Class II recall of its RED 68 Reperfusion Catheter (specific RED68KIT lots) after manufacturing issues were found...

Did Penumbra's Voluntary RED 68 Catheter Recall Just Shift Its Investment Narrative?
TipRanks 2d
Penumbra Maintained at Hold as Deal Dynamics Overshadow Fundamentals; Price Target Reiterated at $374

In a report released today, William Plovanic from Canaccord Genuity maintained a Hold rating on Penumbra, with a price target of $374.00. Unlock powerful inves...

Analyst ratings

92%

of 12 ratings
Buy
8.3%
Hold
91.7%
Sell
0%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.